FMAO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
FMAO is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has a solid long-term income profile and recent dividend growth, but the current setup is mixed: technicals are still constructive, yet the most recent price action is weak, insiders are selling, and analyst sentiment remains only Neutral despite modestly higher price targets. My direct view is to hold off on adding aggressively at this level and wait for either a cleaner pullback or a clearer fundamental re-acceleration before committing fresh capital.
The price closed at 30.08 after a 2.48% regular-session drop from 30.67, which shows short-term weakness. However, the broader trend is still bullish because SMA_5 > SMA_20 > SMA_200, indicating the intermediate and long-term trend remain intact. MACD histogram is positive at 0.18, though it is contracting, which suggests bullish momentum is fading. RSI_6 at 63.8 is not overbought, but it also does not signal a strong fresh entry. Key levels: pivot 30.20, resistance at 31.50 and 32.30, support at 28.91 and 28.11. Overall, the chart is constructive but not compelling enough to call an immediate buy after today's drop.
Recent dividend action is supportive: the company announced a quarterly cash dividend of $0.23 per share, up 4.0% year over year. Analyst price targets have been raised twice in 2026, from $28 to $28.50 and then to $32, showing improving valuation expectations. Congress trading data is also favorable, with 2 purchase transactions and 0 sales in the last 90 days, suggesting positive institutional/political confidence. The company also appears to have some support from fixed-rate loan repricing tailwinds and organic balance sheet growth per analyst commentary.
Insider activity is negative: insiders are selling, and the selling amount rose 349.60% over the last month. Analyst sentiment remains Neutral rather than bullish, so Wall Street is not calling for aggressive upside. The latest market move was negative, with the stock falling 2.48% during regular trading and another 1.92% after hours. The stock trend pattern also suggests near-term weakness, with a 50% chance of -2.6% next day and -5.14% next week. Financial snapshot data was unavailable, limiting confirmation of current earnings momentum.
The latest quarter referenced by analysts was Q1, where Piper Sandler said the company delivered a solid quarter with 3% PPNR upside driven by stronger core fee income. That strength was partly offset by lighter net interest income and net interest margin. The analyst expects fixed-rate loan repricing tailwinds and low-to-mid-single-digit organic balance sheet growth to help restore net interest margin expansion in Q2. This points to stable but not explosive growth trends, with a recent sequential improvement narrative rather than high-growth fundamentals.
Analyst sentiment has improved slightly but remains cautious. Piper Sandler raised its price target from $28 to $28.50 in April and then to $32 in June, while keeping a Neutral rating both times. The trend shows higher valuation expectations and recognition of a solid quarter, but Wall Street still sees the stock as fairly valued rather than a clear outperformer. Pros: dividend growth, improving target, better fee income, potential margin recovery. Cons: Neutral rating, softer NII/NIM, and no strong bullish consensus.
